切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2016, Vol. 04 ›› Issue (02) : 91 -94. doi: 10.3877.cma.j.issn.2095-5820.2016.02.007

所属专题: 文献

综述

α-烯醇化酶的研究进展
张丽红1, 王宏斌1, 杨国灿1, 董学君1,()   
  1. 1. 312000 浙江省绍兴市人民医院临床检验中心
  • 收稿日期:2016-05-06 出版日期:2016-05-28
  • 通信作者: 董学君
  • 基金资助:
    浙江省自然基因项目(LY14H200001); 浙江省医药卫生平台重点资助课题(2013ZDA024); 浙江省医药卫生平台计划项目资助课题(2015DTA018)

Research advance of alpha-enolase

Lihong Zhang1, Hongbin Wang1, Guocan Yang1, Xuejun Dong1,()   

  1. 1. Clinical Laboratory Center, Shaoxing People?s Hospital, Shaoxing 312000, China
  • Received:2016-05-06 Published:2016-05-28
  • Corresponding author: Xuejun Dong
  • About author:
    Corresponding author: Dong Xuejun, Email:
引用本文:

张丽红, 王宏斌, 杨国灿, 董学君. α-烯醇化酶的研究进展[J/OL]. 中华临床实验室管理电子杂志, 2016, 04(02): 91-94.

Lihong Zhang, Hongbin Wang, Guocan Yang, Xuejun Dong. Research advance of alpha-enolase[J/OL]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2016, 04(02): 91-94.

α-烯醇化酶(alpha-enolase, ENO1)在很长一段时间内被认为是一种古老的、功能单一的糖酵解酶。近年发现ENO1除了在糖酵解中发挥作用外,还具有多种生物学功能。目前研究主要集中在ENO1的免疫原性、纤溶酶原受体、肿瘤生长调控作用等方向,而与恶性肿瘤发生、发展的关系研究则备受关注。

Alpha-enolase (ENO1) is considered to be a kind of old, single glycolytic enzyme in a long period. Recently, it is found that ENO1 has various biological functions in addition to glycolysis enzyme. Currently, the research of ENO1 mainly focuses on its role in immunogenicity, fibrinolytic enzyme receptor, tumor suppressor and promot or the relationship between ENO1 and malignant tumor became to be hot area.

1
Zhan P, Wang Y, Zhao S, et al. FBXW7 negatively regulates ENO1 expression and function in colorectal cancer[J].Lab Invest, 2015,95(9):995-1004.
2
Kang HJ, Jung SK, Kim SJ, et al. Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme[J].Acta Crystallogr D Biol Crystallogr, 2008, 64(6):651-657.
3
朱理安,方宁远,高平进, 等. α-烯醇化酶靶向RNA干扰对原代培养乳鼠心肌细胞能量代谢及收缩功能的影响[J]. 中华高血压杂志, 2008,16(1):41-45.
4
Jin X, Xia L, Wang LS, et al. Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats [J]. Proteomics, 2006, 6 (3):1948-1956.
5
Sawhney S, Hood K, Shaw A, et al. Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a Δ133p53α mimic [J]. PLoS One, 2015,10(2):e0116270.
6
揭瑞,董佳慧,韩冬, 等. 人源α-烯醇化酶B细胞表位鉴定及其与牙龈卟啉单胞菌烯醇化酶的交叉反应预测[J]. 中国免疫学杂志, 2015, 31(1):66-72.
7
Lopez-Alemany R, Suelves M, Diaz-Ramos A, et al. Alpha-enolase plasminogen receptor in myogenesis[J]. Front Biosci, 2005,10(1):30-36.
8
刘华,曾洪梅,邱德文. 烯醇化酶在病原生物侵染寄主中的作用[J]. 中国生物防治学报, 2012,28(1):128-132.
9
Funk J, Schaarschmidt B, Slesiona S, et al. The glycolytic enzyme enolase represents a plasminogen-binding protein on the surface of a wide variety of medically important fungal species [J]. Int J Med Microbiol, 2016,306(1):59-68.
10
Hsu KW, Wang AM, Ping YH, et al. Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis [J]. Carcinogenesis, 2014,35(1):208-217.
11
Maranto C, Perconti G, Contino F, et al. Cellular stress induces cap-independent alpha-enolase/ MBP-1 translation [J]. FEBS Lett, 2015,589(16):2110-2116.
12
Ejeskar K, Krona C, Caren H, et a1. Introduction of in vitro transcribed ENOl mRNA into neuroblastoma cells induces cell death [J]. BMC Cancer, 2005,5:161-174.
13
Ghosh AK, Steele R, Ray RB. c-myc Promoter-binding protein1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway [J]. J Biol Chem, 2005,280:14325-14330.
14
Contino F, Mazzarella C, Ferro A, et al. Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer [J]. BMC Cancer, 2013,13:81.
15
Fu QF, Liu Y, Fan Y, et al. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway[J].J Hematol Oncol, 2015,8:22.
16
Hsiao KC, Shih NY, Fang HL, et al. Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target[J].PLoS One, 2013, 8(7):e69354.
17
Warburg O. On the origin of cancer cells [J]. Science, 1956, 123(3191):309-314.
18
Zheng F, Jang WC, Fung FK, et al. Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion [J]. PLoS One, 2016, 11(2):e0147961.
19
White-Al Habeeb NM, Di Meo A, Scorilas A, et al. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma[J].Clin Exp Metastasis, 2015, 32(6):531-541.
20
Yu L, Shen J, Mannoor K, et al. Identification of ENO1 as a potential sputum biomarker for early-stage lung cancer by shotgun proteomics[J]. Clin Lung Cancer, 2014,15(5):372-378,e1.
21
程超,龙孝斌,李欣, 等. α-烯醇化酶在鼻咽癌中的表达[J]. 临床耳鼻咽喉头颈外科杂志, 2011,25(12):554-556.
22
Takashima M, Kuramitsu Y, Yokoyama Y, et al. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis[J]. Proteomics, 2005,5(6):1686-1692.
23
Rojpibulstit P, Kittisenachai S, Puthong S, et al. Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase [J]. Cancer Cell Int, 2014,14:69.
24
Principe M, Ceruti P, Shih NY, et al. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells [J]. Oncotarget, 2015,6(13):11098-11113.
25
Song Y, Luo Q, Long H, et al. Correction: Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma[J]. Mol Cancer, 2015,13:235.
26
Mathivanan S, Simpson, RJ. ExoCarta: A compendium of exosomal proteins and RNA[J]. Proteomics, 2009,9(21):4997-5000.
27
Mazurek S, Boschek CB, Hugo F, et al. Pyruvate kinase type M2 and its role in tumor growth and spreading[J]. Semin Cancer Biol, 2005,15(4):300-308.
28
Tan HT, Low J, Lim SG, et al. Serum autoantibodies as biomarkers for early cancer detection[J]. FEBS J. 2009,276:6880–6904.
29
He P, Naka T, Serada S, et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer[J]. Cancer Sci, 2007,98(8):1234-1240.
30
张丽红,王宏斌,董学君. 血清α-烯醇化酶及其自身抗体对肺癌的诊断价值[J]. 中华实验外科杂志, 2013,30(10):2228-2228.
31
Rattner JB, Martin L, Waisman DM, et al. Autoantibodies to the cen-trosome ( cen-triole ) react with determinants present in the glycolytic enzyme enolase [J]. J Immunol, 1991,146(7): 2341-2344.
32
Weleber RG, Watzke RC, Shults WT, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies [J]. AM J Ophthalmol, 2005,139(5):780-794.
33
Ikura T, Fujishiro H, Takahashi Y, et al. A Patient with Probable Dementia with Lewy Bodies and Positive Autoantibodies against the Anti-NH2-terminal of α-Enolase[J]. Brain Nerve, 2015,67(7):967-972.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[13] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[14] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[15] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
阅读次数
全文


摘要